Platform Overview
Production strength
CDMO is short for Contract Development and Manufacturing Organization, also known as Pharmaceutical Contract Customization R&D and Production Enterprise in Chinese. Its positioning is to provide pharmaceutical and biotechnology companies with customized R&D and production services, especially for innovative drugs, including process research and preparation, process optimization, scale-up production, registration and validation of batch production, and commercial production. CMO is a customized manufacturing enterprise for pharmaceutical contracts. Compared to CDMO, there is a lack of development, which means there is a lack of improvement in research and development. In other words, CMO enterprises are basically not involved in their own technological innovation, relying solely on the production processes and technical support developed by pharmaceutical enterprises, utilizing their own production facilities for process implementation, and providing customers with expanded scale production services. CDMO can provide customized production services from kilogram to ton scale while confirming chemical structure or component experiments, quality research, process research and optimization. It provides innovative process research and development and large-scale production services for pharmaceutical enterprises, replacing pure capacity output with high value-added technology output, and promoting the upgrading of the pharmaceutical CMO industry from capital intensive to technology and capital intensive industries. At present, CDMO enterprises are accelerating the replacement of traditional CMO enterprises.
R&D Center